Pfizer’s 5.9% Yield vs. AbbVie’s 53-Year Dividend Streak: Which Stock Is the Better Buy?
These healthcare dividend stocks appeal to investors in different ways.
·
The Motley Fool
Bloom Energy Stock Has More Than Doubled for 2 Years Running. I’d Keep Buying It Bit by Bit.
Profits have caught up with the stock. So why not buy it all at once?
·
The Motley Fool
Should You Really Buy Nvidia Stock After CEO Jensen Huang’s Exit? Wall Street Has a Clear Answer for Investors.
Jensen Huang’s resignation creates considerable uncertainty, but most analysts think Nvidia stock is deeply undervalued.
·
The Motley Fool
Prediction: Nov. 18 Will Be a Massive Day for the Stock Market
Two major events are on the agenda.
·
The Motley Fool
2 Stocks That Plunged on Oct. 29 to Buy and Hold Through 2030
One dropped on a takeover, the other on a contract outlook. Do their long-term targets make both stocks buys?
·
The Motley Fool
My Top Dividend Growth Stock to Buy Before 2027 and Hold for 20 Years — and It Has Hiked Its Payout by 15%
This 2.4% dividend yield is tied to a company growing briskly -- and growing its payout briskly, too.
·
The Motley Fool
Planning to Claim Social Security at 62? Here Are 3 Critical Questions to Ask Yourself First
Before taking benefits as early as possible, make sure you know what you're getting into.
·
The Motley Fool
